Abstract

Nasopharyngeal carcinoma is a common malignant tumor in southern China, and Guangxi is a high incidence area of nasopharyngeal carcinoma. Recent studies on Genetics and EB virus related research has made a lot of new progress, and these advances have provided more choices for the early diagnosis and treatment of nasopharyngeal carcinoma; In order to identify the incidence of high risk areas, we have carried out a survey of the EB virus antibody test in Cangwu County ,Guangxi province since 1978, and 20 years of follow-up were observed, we found that the early diagnosis rate and the long-term survival rate of nasopharyngeal carcinoma in local place were significantly improved. At present, EB IgA/VCA and EB IgA/EA antibody screening in China has been widely used in nasopharyngeal cancer screening. But there are still many problems at present, and need more and better screening technology to be addressed. In general, early diagnosis and treatment is the main strategy for the prevention and treatment of nasopharyngeal carcinoma, and this work should be kept for a long time. Key words: Nasopharyngeal Neoplasms; serological screening

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.